Comparing CYP26B1 negative and weakly positive tumours with CYP26B1 moderate and strong expressing tumours showed that there was a highly significant association with survival (HR = 1.465, 95%CI = 1.151–1.865, χ2 = 9.832, p = 0.002). The gene discussed is CYP26B1; the disease is neoplasm.